← All indications
Mixed Connective Tissue Disease
A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a speckled epidermal nuclear staining pattern on direct immunofluorescence.
Drugs by status
Phase 3 trials (2)
Phase 2 trials (1)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (2)
Organization Involved with Other Experimental Indications (1)